Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Hemoglobin; F (fetal), chemical

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 83030 refers to a laboratory test specifically designed to measure fetal hemoglobin, also known as hemoglobin F (HbF). Hemoglobin is a crucial protein found in red blood cells (RBCs) that is responsible for transporting oxygen throughout the body. Fetal hemoglobin differs from adult hemoglobin in that it has a higher affinity for oxygen, which is essential for the developing fetus to receive adequate oxygen supply during gestation. Hemoglobin F is typically present in the fetus starting around 10 weeks of gestation and continues to be produced for approximately six months after birth. In certain medical conditions, such as thalassemia, hemoglobin F levels may remain elevated beyond the typical timeframe, and in adults with sickle cell disease, pharmacological agents like hydroxyurea and recombinant erythropoietin can stimulate the production of fetal hemoglobin. The measurement of hemoglobin F is clinically significant as it aids in the evaluation and diagnosis of various hematological disorders, including hemolytic anemia, hereditary persistence of fetal hemoglobin, thalassemia, and sickle cell disease. Additionally, this test can help determine the necessity for further doses of Rh-immune globulin in Rh-negative mothers who have delivered Rh-positive infants. The blood sample required for this test is obtained through a venipuncture, which is a separately reportable procedure. The analysis of hemoglobin F can be performed using advanced laboratory techniques such as high-performance liquid chromatography, flow cytometry, or mixed field agglutination, ensuring accurate and reliable results.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The hemoglobin F (fetal) test, coded as CPT® 83030, is indicated for several clinical scenarios, particularly in the evaluation and diagnosis of specific hematological conditions. The following are the primary indications for performing this test:

  • Hemolytic Anemia - This condition involves the premature destruction of red blood cells, and measuring fetal hemoglobin can help in understanding the underlying causes.
  • Hereditary Persistence of Fetal Hemoglobin - This genetic condition results in the continued production of fetal hemoglobin into adulthood, and the test can confirm its presence.
  • Thalassemia - A group of inherited blood disorders characterized by abnormal hemoglobin production, where fetal hemoglobin levels may be relevant for diagnosis and management.
  • Sickle Cell Disease - In patients with this condition, fetal hemoglobin can be reactivated to alleviate symptoms, making its measurement important for treatment planning.
  • Evaluation of Rh-Immune Globulin Needs - In Rh-negative mothers who have given birth to Rh-positive infants, this test can help determine if additional doses of Rh-immune globulin are necessary to prevent Rh sensitization.

2. Procedure

The procedure for measuring fetal hemoglobin involves several key steps that ensure accurate results. The following outlines the procedural steps associated with CPT® 83030:

  • Step 1: Patient Preparation - Prior to the test, the patient may be instructed to avoid certain medications or supplements that could interfere with the results. However, specific preparation guidelines should be followed as per the laboratory's protocols.
  • Step 2: Venipuncture - A qualified healthcare professional performs a venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to draw the necessary volume of blood for testing. The procedure is performed using sterile techniques to minimize the risk of infection.
  • Step 3: Sample Handling - Once the blood sample is collected, it must be properly labeled and transported to the laboratory under appropriate conditions to preserve the integrity of the sample for analysis.
  • Step 4: Laboratory Analysis - The blood sample is analyzed using one of several laboratory techniques, such as high-performance liquid chromatography, flow cytometry, or mixed field agglutination. Each method has its own advantages and is selected based on the laboratory's capabilities and the specific requirements of the test.
  • Step 5: Result Interpretation - After analysis, the results are interpreted by qualified laboratory personnel. The levels of fetal hemoglobin are reported, and any significant findings are communicated to the requesting physician for further clinical decision-making.

3. Post-Procedure

After the procedure, patients may experience minor discomfort or bruising at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for the hemoglobin F test, as it is a routine laboratory test. However, patients should be advised to contact their healthcare provider if they experience excessive bleeding, swelling, or signs of infection at the puncture site. The results of the test will be reviewed by the physician, who will discuss the findings with the patient and determine any necessary follow-up actions or treatments based on the results.

Short Descr HEMOGLOBIN F FETAL CHEMICAL
Medium Descr HEMOGLOBIN F FETAL CHEMICAL
Long Descr Hemoglobin; F (fetal), chemical
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
GA Waiver of liability statement issued as required by payer policy, individual case
Date
Action
Notes
2023-01-01 Note Short description changed.
2011-01-01 Changed Short description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"